Stockscreener 앱 받기
3.18
1.27%
0.04
Mural Oncology Plc 주식(MURA)의 최신 뉴스
2025 will be a big year for Mural Oncology's drugs in development - The Business Journals
BNP Paribas Financial Markets Lowers Stake in Mural Oncology plc (NASDAQ:MURA) - Defense World
Mural Oncology stock hits 52-week low at $2.87 By Investing.com - Investing.com UK
Mural Oncology CEO Caroline Loew sells shares worth $9,394 - Investing.com
Mural Oncology CEO Caroline Loew sells shares worth $9,394 By Investing.com - Investing.com UK
Mural Oncology plc (NASDAQ:MURA) Shares Sold by Verition Fund Management LLC - MarketBeat
Mural Oncology GAAP EPS of -$1.84; reaffirms financial guidance - MSN
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Mural Oncology Awards Key Talent with Stock Options and RSU Inducement Grants - StockTitan
Alkermes to Participate in Upcoming Investor Conferences - Quantisnow
Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Rodman & Renshaw Initiates Coverage of Mural Oncology (MURA) with Buy Recommendation - MSN
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer - The Manila Times
Mural Oncology's Cancer Drug Shows 33% Response Rate in Melanoma Trial Data | MURA Stock News - StockTitan
HC Wainwright Raises Earnings Estimates for Mural Oncology - Defense World
HC Wainwright Predicts Stronger Earnings for Mural Oncology - MarketBeat
MURAMural Oncology plc Ordinary Shares Latest Stock News & Market Updates - StockTitan
Armistice Capital, LLC Increases Stake in Mural Oncology PLC - GuruFocus.com
Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress - The Manila Times
Mural Oncology plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Mural Oncology Reports 38% Lower Net Loss, Hits Trial Enrollment Milestones in Q3 | MURA Stock News - StockTitan
HC Wainwright Reaffirms "Buy" Rating for Mural Oncology (NASDAQ:MURA) - MarketBeat
Mural Oncology to Participate in Two Upcoming Investor Conferences - The Manila Times
Mural Oncology (MURA) to Present at Major Healthcare Investor Conferences | MURA Stock News - StockTitan
Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times
Mural Oncology Reports Promising Cancer Trial Data, Plans Key 2025 Readouts | MURA Stock News - StockTitan
Vanguard Group Inc's Strategic Reduction in Mural Oncology PLC H - GuruFocus.com
Mural Oncology CFO Adam Cutler sells $25,305 in company stock By Investing.com - Investing.com Canada
Mural Oncology plc (NASDAQ:MURA) CFO Adam D. Cutler Sells 7,421 Shares - MarketBeat
Mural Oncology CFO Adam Cutler sells $25,305 in company stock - Investing.com
Short Interest in Mural Oncology plc (NASDAQ:MURA) Decreases By 15.7% - MarketBeat
HC Wainwright Comments on Mural Oncology Q3 Earnings - MarketBeat
Mural Oncology (NASDAQ:MURA) Coverage Initiated at HC Wainwright - MarketBeat
H.C. Wainwright initiates coverage on Mural Oncology stock with Buy rating - Investing.com UK
167,644 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Squarepoint Ops LLC - MarketBeat
232,100 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Renaissance Technologies LLC - MarketBeat
Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times
Raymond James Begins Coverage on Mural Oncology (NASDAQ:MURA) - Defense World
Mural Oncology (NASDAQ:MURA) Coverage Initiated by Analysts at Raymond James - MarketBeat
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Rhumbline Advisers Makes New $34,000 Investment in Mural Oncology plc (NASDAQ:MURA) - Defense World
Point72 Asia Singapore Pte. Ltd. Invests $84,000 in Mural Oncology plc (NASDAQ:MURA) - Defense World
Mural Oncology Highlights Clinical Trials During It's Maiden Investor Day - Forbes
Armistice Capital LLC Takes Position in Mural Oncology plc (NASDAQ:MURA) - Defense World
1,688,000 Shares in Mural Oncology plc (NASDAQ:MURA) Acquired by Armistice Capital LLC - MarketBeat
Mural Oncology's First Virtual Investor Day to Highlight Late-Stage Clinical Progress - The Manila Times
Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress - StockTitan
2.88%
2.65%
자본화:
|
볼륨(24시간):